2-Aminopyridine

2-Aminopyridine

SCHEMBL5268880

CN(C)c1ccncc1.Nc1ccccn1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 1/20 0.59
▸ NOS1 P29475 1/20 0.59
▸ NOS2 P35228 1/20 0.59
▸ PI4KA P42356 1/20 0.59
▸ PI4K2B Q8TCG2 1/20 0.59
▸ PI4K2A Q9BTU6 1/20 0.59
▸ PI4KB Q9UBF8 1/20 0.59
▸ CHRM5 P08912 1/20 0.59
▸ CHKA P35790 1/20 0.59
▸ MAPT P10636 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ MAOA P21397 3/20 0.45
▸ MAOB P27338 3/20 0.45
▸ NPC1 O15118 5/20 0.43
▸ RAB9A P51151 5/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ ALOX15 P16050 3/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ HBB P68871 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Aminopyridine SCHEMBL10589578 0.85 ALDH1A1 (0.59) NOS3NOS1NOS2PI4KAPI4K2B
2-Aminopyridine SCHEMBL28747830 0.82 NOS3 (0.80) NOS3NOS1NOS2PI4KAPI4K2B
2-Aminopyridine SCHEMBL9487893 0.80 NOS3 (0.52) NOS3NOS1NOS2PI4KAPI4K2B
2-Aminopyridine SCHEMBL27970817 0.80 NOS3 (0.84) NOS3NOS1NOS2PI4KAPI4K2B
SCHEMBL31256490 0.79 CHRM5 (0.94) CHRM5CHKAMAPTSMN1; SMN2NPC1
SCHEMBL28388870 0.79 CHRM5 (0.61) CHRM5CHKAMAPTSMN1; SMN2MAOA
2-Aminopyridine SCHEMBL759357 0.78 NOS3 (0.73) NOS3NOS1NOS2PI4KAPI4K2B
2-Chloropyridine SCHEMBL14882379 0.78 TDP1 (0.59) CHRM5CHKAMAPTSMN1; SMN2MAOA
Pyridine SCHEMBL1830428 0.78 CHRM5 (0.80) CHRM5CHKAMAPTSMN1; SMN2MAOA
2-Aminopyridine SCHEMBL6268366 0.78 NOS3 (0.80) NOS3NOS1NOS2PI4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0366206-B1 REMOVING HYDROGEN SULPHIDE FROM A GAS MIXTURE SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1993-01-13 — — EP claimed
CN-101125916-A Biodegradation polymer and its preparing process and application TIANDA DRUG ZHUHAI CO LTD (CN) 2008-02-20 — — CN disclosed
EP-1838363-A2 BIODEGRADABLE COATING COMPOSITIONS COMPRISING BLENDS SurModics, Inc. (US) 2007-10-03 — — EP disclosed
US-20060198868-A1 Biodegradable coating compositions comprising blends Surmodics Coatings, LLC 2006-09-07 — — US disclosed
US-7101568-B2 Methods and compositions for treating solid tumors GUILFORD PHARMACEUTICALS, INC. (US) 2006-09-05 — — US disclosed
WO-2006074391-A2 BIODEGRADABLE COATING COMPOSITIONS COMPRISING BLENDS SURMODICS, INC. (US) 2006-07-13 — — WO disclosed
US-20060147491-A1 Biodegradable coating compositions including multiple layers Surmodics Coatings, LLC 2006-07-06 — — US disclosed
US-20060024350-A1 Biodegradable ocular devices, methods and systems SURMODICS MD, LLC 2006-02-02 — — US disclosed
US-20060018948-A1 Biodegradable implantable medical devices, methods and systems SURMODICS MD, LLC 2006-01-26 — — US disclosed
WO-2006002399-A2 BIODEGRADABLE IMPLANTABLE MEDICAL DEVICES, METHODS AND SYSTEMS SURMODICS, INC. (US) 2006-01-05 — — WO disclosed
US-5912225-A Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same JOHNS HOPKINS UNIV. SCHOOL OF MEDICINE (US) 1999-06-15 — — US disclosed
WO-1999000446-A9 SOLUTION POLYMERIZATION OF HIGH MOLECULAR WEIGHT POLY(PHOSPHOESTERS) IN TOLUENE GUILFORD PHARM INC (US) 1999-05-06 — — WO disclosed
WO-1998044021-A9 BIODEGRADABLE TEREPHTHALATE POLYESTER-POLY(PHOSPHATE) POLYMERS, COMPOSITIONS, ARTICLES, AND METHODS FOR MAKING AND USING THE SAME GUILFORD PHARM INC (US) 1999-04-22 — — WO disclosed
WO-1999000446-A1 SOLUTION POLYMERIZATION OF HIGH MOLECULAR WEIGHT POLY(PHOSPHOESTERS) IN TOLUENE GUILFORD PHARMACEUTICALS INC. (US) 1999-01-07 — — WO disclosed
WO-1998058012-A1 TWO-STAGE SOLUTION POLYMERIZATION OF HIGH MOLECULAR WEIGHT POLY(PHOSPHOESTERS) GUILFORD PHARMACEUTICALS INC. (US) 1998-12-23 — — WO disclosed
WO-1998048859-A1 BIODEGRADABLE COMPOSITIONS COMPRISING POLY(CYCLOALIPHATIC PHOSPHOESTER) COMPOUNDS, ARTICLES, AND METHODS FOR USING THE SAME GUILFORD PHARMACEUTICALS INC. (US) 1998-11-05 — — WO disclosed
WO-1998046286-A1 BIODEGRADABLE COMPOUNDS, COMPOSITIONS, ARTICLES AND METHODS FOR MAKING AND USING THE SAME JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1998-10-22 — — WO disclosed
WO-1998044021-A1 BIODEGRADABLE TEREPHTHALATE POLYESTER-POLY(PHOSPHATE) POLYMERS, COMPOSITIONS, ARTICLES, AND METHODS FOR MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS INC. (US) 1998-10-08 — — WO disclosed
WO-1998044020-A1 BIODEGRADABLE POLYMERS CHAIN-EXTENDED BY PHOSPHATES, COMPOSITIONS, ARTICLES AND METHODS FOR MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS INC. (US) 1998-10-08 — — WO disclosed
US-5235063-A Acetal derivatives of 3-aryl-2-oxazolidine; antidepressants DELALANDE S.A. (FR) 1993-08-10 — — US disclosed
Send feedback